Phibro Animal Health (NASDAQ:PAHC) Sees Strong Trading Volume – Still a Buy?

Phibro Animal Health Co. (NASDAQ:PAHC) shares saw unusually-high trading volume on Wednesday . Approximately 326,135 shares changed hands during trading, an increase of 112% from the previous session’s volume of 153,695 shares.The stock last traded at $21.66 and had previously closed at $20.68.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on PAHC. StockNews.com upgraded shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Barclays lifted their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price for the company. Finally, Morgan Stanley raised their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Price Performance

The business’s fifty day moving average price is $22.89 and its 200-day moving average price is $21.06. The company has a market capitalization of $870.00 million, a P/E ratio of 49.95, a P/E/G ratio of 0.58 and a beta of 0.53. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.23%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

Institutional Trading of Phibro Animal Health

Several hedge funds have recently added to or reduced their stakes in the business. Quantbot Technologies LP purchased a new stake in Phibro Animal Health in the third quarter worth $70,000. nVerses Capital LLC purchased a new position in shares of Phibro Animal Health in the 3rd quarter valued at approximately $70,000. China Universal Asset Management Co. Ltd. grew its stake in Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after purchasing an additional 1,522 shares during the period. CWM LLC boosted its holdings in shares of Phibro Animal Health by 190.8% during the 3rd quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after buying an additional 4,175 shares in the last quarter. Finally, Algert Global LLC purchased a new stake in shares of Phibro Animal Health in the 2nd quarter worth about $193,000. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.